QQQ   310.73 (-0.32%)
AAPL   155.94 (+3.39%)
MSFT   262.05 (-0.96%)
META   193.00 (+2.24%)
GOOGL   106.89 (-0.79%)
AMZN   107.65 (-4.66%)
TSLA   196.23 (+4.23%)
NVDA   214.97 (-0.98%)
NIO   11.58 (-3.18%)
BABA   106.89 (-2.60%)
AMD   87.64 (-0.76%)
T   19.89 (-1.92%)
F   13.43 (-6.22%)
MU   63.23 (+0.09%)
CGC   3.03 (-3.50%)
GE   82.92 (-1.22%)
DIS   112.10 (-0.98%)
AMC   6.63 (+9.05%)
PFE   44.21 (-0.29%)
PYPL   87.17 (+0.24%)
NFLX   375.45 (+2.33%)
QQQ   310.73 (-0.32%)
AAPL   155.94 (+3.39%)
MSFT   262.05 (-0.96%)
META   193.00 (+2.24%)
GOOGL   106.89 (-0.79%)
AMZN   107.65 (-4.66%)
TSLA   196.23 (+4.23%)
NVDA   214.97 (-0.98%)
NIO   11.58 (-3.18%)
BABA   106.89 (-2.60%)
AMD   87.64 (-0.76%)
T   19.89 (-1.92%)
F   13.43 (-6.22%)
MU   63.23 (+0.09%)
CGC   3.03 (-3.50%)
GE   82.92 (-1.22%)
DIS   112.10 (-0.98%)
AMC   6.63 (+9.05%)
PFE   44.21 (-0.29%)
PYPL   87.17 (+0.24%)
NFLX   375.45 (+2.33%)
QQQ   310.73 (-0.32%)
AAPL   155.94 (+3.39%)
MSFT   262.05 (-0.96%)
META   193.00 (+2.24%)
GOOGL   106.89 (-0.79%)
AMZN   107.65 (-4.66%)
TSLA   196.23 (+4.23%)
NVDA   214.97 (-0.98%)
NIO   11.58 (-3.18%)
BABA   106.89 (-2.60%)
AMD   87.64 (-0.76%)
T   19.89 (-1.92%)
F   13.43 (-6.22%)
MU   63.23 (+0.09%)
CGC   3.03 (-3.50%)
GE   82.92 (-1.22%)
DIS   112.10 (-0.98%)
AMC   6.63 (+9.05%)
PFE   44.21 (-0.29%)
PYPL   87.17 (+0.24%)
NFLX   375.45 (+2.33%)
QQQ   310.73 (-0.32%)
AAPL   155.94 (+3.39%)
MSFT   262.05 (-0.96%)
META   193.00 (+2.24%)
GOOGL   106.89 (-0.79%)
AMZN   107.65 (-4.66%)
TSLA   196.23 (+4.23%)
NVDA   214.97 (-0.98%)
NIO   11.58 (-3.18%)
BABA   106.89 (-2.60%)
AMD   87.64 (-0.76%)
T   19.89 (-1.92%)
F   13.43 (-6.22%)
MU   63.23 (+0.09%)
CGC   3.03 (-3.50%)
GE   82.92 (-1.22%)
DIS   112.10 (-0.98%)
AMC   6.63 (+9.05%)
PFE   44.21 (-0.29%)
PYPL   87.17 (+0.24%)
NFLX   375.45 (+2.33%)
OTCMKTS:ABVC

ABVC BioPharma - ABVC Stock Forecast, Price & News

$0.71
-0.02 (-2.74%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.70
$0.74
50-Day Range
$0.60
$1.07
52-Week Range
$0.50
$3.13
Volume
68,010 shs
Average Volume
2.45 million shs
Market Capitalization
$23.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ABVC stock logo

About ABVC BioPharma (OTCMKTS:ABVC) Stock

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

Receive ABVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter.

ABVC Stock News Headlines

The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
ABVC: Key Medical Venues Participating in Clinical Studies
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
ABVC Biopharma Announces Letter to Shareholders
ABVC Biopharma Inc
ABVC Provides Oncology Pipeline Updates
ABVC BioPharma Provides Vitargus(R) Update
ABVC BioPharma Provides Vitargus Update
See More Headlines
Receive ABVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter.

ABVC Company Calendar

Last Earnings
11/14/2022
Today
2/03/2023
Next Earnings (Estimated)
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ABVC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-12,840,000.00
Pretax Margin
-5,208.75%

Debt

Sales & Book Value

Annual Sales
$360,000.00
Book Value
$0.31 per share

Miscellaneous

Free Float
18,470,000
Market Cap
$23.17 million
Optionable
Not Optionable
Beta
0.46

Key Executives

  • Eugene Jiang
    Chairman & Chief Business Officer
  • Howard Doong
    President & Chief Executive Officer
  • Leeds Chow
    Chief Financial Officer & Accounting Officer
  • Chi-Hsin King
    Chief Scientific Officer
  • Tsung-Shann Jiang
    Director & Chief Strategy Officer













ABVC Stock - Frequently Asked Questions

Should I buy or sell ABVC BioPharma stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ABVC BioPharma in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ABVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABVC, but not buy additional shares or sell existing shares.
View ABVC analyst ratings
or view top-rated stocks.

How have ABVC shares performed in 2023?

ABVC BioPharma's stock was trading at $0.6250 on January 1st, 2023. Since then, ABVC stock has increased by 13.6% and is now trading at $0.71.
View the best growth stocks for 2023 here
.

When is ABVC BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our ABVC earnings forecast
.

How were ABVC BioPharma's earnings last quarter?

ABVC BioPharma, Inc. (OTCMKTS:ABVC) issued its quarterly earnings data on Monday, November, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.09. The business had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.03 million.

What is ABVC BioPharma's stock symbol?

ABVC BioPharma trades on the OTCMKTS under the ticker symbol "ABVC."

How do I buy shares of ABVC BioPharma?

Shares of ABVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ABVC BioPharma's stock price today?

One share of ABVC stock can currently be purchased for approximately $0.71.

How much money does ABVC BioPharma make?

ABVC BioPharma (OTCMKTS:ABVC) has a market capitalization of $23.17 million and generates $360,000.00 in revenue each year. The company earns $-12,840,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

How can I contact ABVC BioPharma?

ABVC BioPharma's mailing address is 44370 Old Warm Springs Blvd, Fremont CA, 94538. The official website for the company is www.ambrivis.com. The company can be reached via phone at (510) 668-0881.

This page (OTCMKTS:ABVC) was last updated on 2/3/2023 by MarketBeat.com Staff